Ophthalmology

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Potential of antioxidant neuroretinoprotection in the treatment of primary open-angle glaucoma

E.A. EGOROV¹, A.V. KUROEDOV¹, ², N.A. GAVRILOVA³, A.E. YAVORSKY⁴, E.A. GORNOSTAYEVA⁵

¹Pirogov Russian National Medical Research University, Moscow, Russia;
²Mandryka Central Military Clinical Hospital,
³Russian University of Medicine, Moscow, Russia;
⁴V.P. Vykhodtsev Clinical Ophthalmological Hospital, Omsk, Russia;
⁵Zrenie Diagnostic Center, Saint Petersburg, Russia

Place of publication:
Bulletin of Ophthalmology 2025, Vol. 141, No. 4, pp. 49–59
https://doi.org/10.17116/oftalma202514104149

Neuroprotective therapy with age -related macular degeneration

Authors:
VLASOVA A.S. 1*, PETROV S.A. 1*, 2*, RENZYAK E.V. 1*, 3*

1* West Siberian Institute of Postgraduate Medical Education, Tyumen, Russia;
2* Tyumen Scientific Center of the Siberian Branch of the Russian Academy of Sciences, Tyumen, Russia;
3* Khanty-Mansiysk Autonomous Okrug - Yugra District Clinical Hospital, Khanty-Mansiysk, Russia

The value of mitochondrial dysfunction in stabilization

Registered on ClinicalTrials

VLASOVA A.S. ^1.4*, MALISHEVSKAYA T.N. ^2*, PETROV S.A.^1.3*, GUBIN D.G. ^5*, PETROV S.YU. ^2*, FILIPPOVA Yu.E. ^1*

^1*West Siberian Institute of Postgraduate Medical Education, Tyumen, Russia;
^2*Helmholtz National Medical Research Center of Eye Diseases, Moscow, Russia;
^3*Tyumen Scientific Center of the Siberian Branch of the Russian Academy of Sciences, Tyumen, Russia;
^4*Regional Ophthalmological Dispensary, Tyumen, Russia;
^5*Tyumen State Medical University, Tyumen, Russia

The effect of antioxidant therapy on some pathogenetic factors of primary open -angle glaucoma

Authors:
T.N. MALISHEVSKAYA¹, Yu.E. FILIPPOVA²

¹Federal State Budgetary Institution "Helmholtz National Medical Research Center for Eye Diseases" of the Ministry of Health of the Russian Federation, Moscow, Russia;
²State Autonomous Healthcare Institution of the Tyumen Region "Regional Ophthalmological Dispensary", Tyumen, Russia

The possibilities and results of the use of antioxidant therapy in ophthalmological practice

Authors:
A.B. MOVSISYAN^1,2, Zh.G. OGANEZOVA^2,3, E.A. EGOROV²

¹Hospital for War Veterans No. 2 of the Moscow Health Department, Moscow, Russia;
²Pirogov Russian National Research Medical University, Moscow, Russia;
³Bochkov Medical Genetic Research Center, Moscow, Russia

The use of Mexidol in the treatment of primary open -angle glaucoma

Authors:
I.A. LOSKUTOV, O.M. ANDRYUKHINA, A.A. KOVRIZHKINA

Moscow Regional Research Clinical Institute. M.F. Vladimir

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:
E.S. LEONOVA^1,2, S.V. POLYAKOV^1,2, M.A. POZDNYAKOVA², E.P. YARYGINA³, S.O. SEMISYNOV²

^1.NGO "Road Clinical Hospital at Gorky Station of JSC "Russian Railways", Inter-Road Ophthalmology Center
^2.State Budgetary Educational Institution of Higher Professional Education "Nizhny Novgorod State Medical Academy"
^3.State Budgetary Healthcare Institution of the Nizhny Novgorod Region "City Hospital No. 35", City Glaucoma Center

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:

E.S. Leonova1, 2, S.V. Polyakov1, 2, M.A. Pozdnyakova2, E.P. Yarygin3, S.O. Semisov2

1 nose "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology, 18 Lenin Ave., Nizhny Novgorod, Russian Federation, 603140;

2GBOU VPO Nizhny Novgorod State Medical Academy, pl. Minina and Pozharsky, 10/1, Nizhny Novgorod, Russian Federation, 603950;

3GBUZ but "City Hospital No. 35", City Glack Center, ul. Osharskaya, 15, Nizhny Novgorod, Russian Federation, 603005

Place of publication:

Bulletin of ophthalmology 6, 2015

Assessment of Mexidol's effectiveness in the complex treatment of glaucomone neuropathy

Authors:
A.N. BOLATBEKOVA, D.E. KOPBAEVA, A.I. ARINOVA, B.S. ABRAKHMANOVA

LLP "Center for Eye Microsurgery", Karaganda;
KGP "Regional Clinical Hospital", Karaganda;
Karaganda State Medical University, Karaganda

Our experience in the use of Mexidol in the complex treatment of patients with primary open -angle glaucoma

Authors:
E.A. AFONINA, M.A. LEVKO, L.V. CHEKUROVA, T.I. KOSACHEVA

SZGMU them. I.I. Mechnikov, St. Petersburg

Antioxidant drug in neuroprotective therapy for glaucoma

Authors:
E.A. EGOROV¹, A.A. GVETADZE¹, N.G. DAVYDOVA²

¹Pirogov Russian National Research Medical University;
²Helmholtz Moscow Research Institute of Eye Diseases of the Russian Ministry of Health

The effectiveness of the use of 3-oxypyridine and amber acid derivatives in the complex treatment of primary open-angle glaucoma

Authors:
I.A. VOLCHEGORSKY¹, E.V. ROUND¹, O.V. SOLYANNIKOVA¹, V.S. RYKUN¹, M.S. SUMINA², V.N. DMITRIENKO², E.V. BERDNIKOVA¹

¹Department of Pharmacology (Head - Prof. I.A. Volchegorsky) and Department of Eye Diseases (Head - V.S. Rykun) State Budgetary Educational Institution of Higher Professional Education "Chelyabinsk State Medical Academy" of the Ministry of Health and Social Development of the Russian Federation
²Microsurgery Department (Head - V.N. Dmitrienko) State Medical Healthcare Institution "Chelyabinsk Regional Clinical Hospital", Medgorodok

The influence of a water -soluble antioxidant drug (Mexidol) on the sensitivity of the optic nerve and blood flow velocity in the arteries of the eyeball and orbit in patients with the primary open -angle glaucoma

Authors:

I.A. VOLCHEGORSKY¹, E.V. ROUND¹, O.V. SOLYANNIKOVA¹, V.S. RYKUN¹, E.V. BERDNIKOVA¹, M.S. SUMINA², V.N. DMITRIENKO²

¹State Budgetary Educational Institution of Higher Professional Education "Chelyabinsk State Medical Academy" of the Ministry of Health and Social Development of the Russian Federation;
²State Medical and Public Health Institution "Chelyabinsk Regional Clinical Hospital"

Mexidol in the complex treatment of glaucoma

Author:
E.A. EGOROV, N.G. DAVYDOVA, I.A. ROMANENKO, N.D. NOVIKOVA

RNIMU named after N.I. Pirogov, GB of GB named after Helmholtz, Moscow